日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/21 | 1,675 | 1,676 | 1,652 | 1,652 | -23 | -1.4% | 4,300 |
| 2022/12/20 | 1,659 | 1,690 | 1,659 | 1,675 | +4 | +0.2% | 5,300 |
| 2022/12/19 | 1,675 | 1,680 | 1,661 | 1,671 | -4 | -0.2% | 5,300 |
| 2022/12/16 | 1,685 | 1,685 | 1,675 | 1,675 | -15 | -0.9% | 5,800 |
| 2022/12/15 | 1,682 | 1,691 | 1,682 | 1,690 | +8 | +0.5% | 700 |
| 2022/12/14 | 1,668 | 1,682 | 1,668 | 1,682 | +14 | +0.8% | 1,800 |
| 2022/12/13 | 1,685 | 1,685 | 1,663 | 1,668 | -2 | -0.1% | 4,200 |
| 2022/12/12 | 1,698 | 1,700 | 1,660 | 1,670 | +8 | +0.5% | 9,000 |
| 2022/12/09 | 1,655 | 1,662 | 1,654 | 1,662 | +11 | +0.7% | 4,800 |
| 2022/12/08 | 1,682 | 1,682 | 1,651 | 1,651 | -23 | -1.4% | 6,000 |
| 2022/12/07 | 1,680 | 1,690 | 1,674 | 1,674 | -6 | -0.4% | 6,400 |
| 2022/12/06 | 1,701 | 1,710 | 1,680 | 1,680 | -31 | -1.8% | 3,700 |
| 2022/12/05 | 1,681 | 1,713 | 1,681 | 1,711 | +25 | +1.5% | 5,000 |
| 2022/12/02 | 1,683 | 1,699 | 1,680 | 1,686 | -14 | -0.8% | 7,800 |
| 2022/12/01 | 1,698 | 1,704 | 1,681 | 1,700 | +1 | +0.1% | 10,100 |
| 2022/11/30 | 1,707 | 1,709 | 1,698 | 1,699 | -1 | -0.1% | 3,900 |
| 2022/11/29 | 1,705 | 1,732 | 1,700 | 1,700 | -4 | -0.2% | 9,000 |
| 2022/11/28 | 1,699 | 1,718 | 1,691 | 1,704 | +14 | +0.8% | 11,700 |
| 2022/11/25 | 1,685 | 1,690 | 1,681 | 1,690 | +9 | +0.5% | 6,200 |
| 2022/11/24 | 1,668 | 1,682 | 1,668 | 1,681 | +16 | +1% | 10,900 |
| 2022/11/22 | 1,666 | 1,669 | 1,656 | 1,665 | +3 | +0.2% | 7,100 |
| 2022/11/21 | 1,663 | 1,663 | 1,655 | 1,662 | -1 | -0.1% | 4,100 |
| 2022/11/18 | 1,667 | 1,667 | 1,655 | 1,663 | +14 | +0.8% | 1,600 |
| 2022/11/17 | 1,660 | 1,684 | 1,649 | 1,649 | -6 | -0.4% | 2,400 |
| 2022/11/16 | 1,671 | 1,671 | 1,653 | 1,655 | -16 | -1% | 5,400 |
| 2022/11/15 | 1,685 | 1,685 | 1,669 | 1,671 | -15 | -0.9% | 2,400 |
| 2022/11/14 | 1,697 | 1,697 | 1,667 | 1,686 | +6 | +0.4% | 11,100 |
| 2022/11/11 | 1,686 | 1,690 | 1,673 | 1,680 | -6 | -0.4% | 4,900 |
| 2022/11/10 | 1,672 | 1,686 | 1,672 | 1,686 | +14 | +0.8% | 10,300 |
| 2022/11/09 | 1,665 | 1,674 | 1,662 | 1,672 | +7 | +0.4% | 2,900 |
| 2022/11/08 | 1,650 | 1,674 | 1,649 | 1,665 | +20 | +1.2% | 7,900 |
| 2022/11/07 | 1,675 | 1,675 | 1,642 | 1,645 | -17 | -1% | 9,200 |
| 2022/11/04 | 1,701 | 1,701 | 1,662 | 1,662 | -41 | -2.4% | 11,000 |
| 2022/11/02 | 1,684 | 1,703 | 1,684 | 1,703 | +12 | +0.7% | 6,600 |
| 2022/11/01 | 1,714 | 1,714 | 1,677 | 1,691 | -23 | -1.3% | 13,200 |
| 2022/10/31 | 1,700 | 1,721 | 1,680 | 1,714 | +35 | +2.1% | 12,300 |
| 2022/10/28 | 1,709 | 1,730 | 1,679 | 1,679 | -40 | -2.3% | 35,200 |
| 2022/10/27 | 1,742 | 1,742 | 1,713 | 1,719 | -18 | -1% | 4,800 |
| 2022/10/26 | 1,707 | 1,738 | 1,707 | 1,737 | +39 | +2.3% | 7,000 |
| 2022/10/25 | 1,706 | 1,706 | 1,694 | 1,698 | +3 | +0.2% | 4,900 |
| 2022/10/24 | 1,702 | 1,707 | 1,695 | 1,695 | -7 | -0.4% | 7,800 |
| 2022/10/21 | 1,710 | 1,710 | 1,702 | 1,702 | -8 | -0.5% | 3,100 |
| 2022/10/20 | 1,722 | 1,722 | 1,701 | 1,710 | -14 | -0.8% | 6,700 |
| 2022/10/19 | 1,716 | 1,724 | 1,713 | 1,724 | +6 | +0.3% | 1,400 |
| 2022/10/18 | 1,727 | 1,727 | 1,706 | 1,718 | +2 | +0.1% | 5,600 |
| 2022/10/17 | 1,702 | 1,727 | 1,702 | 1,716 | -10 | -0.6% | 11,000 |
| 2022/10/14 | 1,735 | 1,744 | 1,725 | 1,726 | -1 | -0.1% | 6,300 |
| 2022/10/13 | 1,736 | 1,745 | 1,726 | 1,727 | -20 | -1.1% | 6,400 |
| 2022/10/12 | 1,767 | 1,767 | 1,736 | 1,747 | +18 | +1% | 3,300 |
| 2022/10/11 | 1,753 | 1,757 | 1,729 | 1,729 | -24 | -1.4% | 13,600 |
601～
650
件表示中 / 3714件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 147,800円 | +7.5% | -77.4% | 3.38% | 35.56倍 | 0.28倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ペルセウス | 42,700円 | +25.0% | - | 0.00% | - | 4.66倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体（ＡＤＣ）開発 |
| ＯＴＳ | 2,200円 | +33.3% | - | 0.00% | - | 9.20倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| ＤＥＬＴＡ－Ｐ | 60,000円 | - | - | 0.00% | - | 21.24倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
| カルナバイオ | 32,200円 | +13.5% | - | 0.00% | - | 2.49倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
市場注目の銘柄
チャート関連のコラム
